跳至主要内容
临床试验/NCT06665438
NCT06665438招募中3 期

Impact of Dexmedetomidine Add to Intra-articular Bupivacaine for Post Operative Analgesia After Knee Arthroscopic Surgery

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2024年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
入组人数
75
试验地点
1
主要终点
Change on the visual analog scale (VAS) for pain (0 = no pain to 100 = the maximum pain )to assessment the duration of analgesia following the surgery

研究概览

简要总结

The aim of this study to compare the analgesic effects of intraarticular dexmedetomidine added to bupivacaine with those of bupivacaine alone after knee arthroscopy

详细描述

prospective double-blind study perform on 75 patients candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy refer to the clinic of Al Azhar University Hospital, Assiut, Egypt, to evaluate the effect of adding dexmedetomidine to intra articular bupivacaine injection on postoperative pain after knee arthroscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-II patients
  • Either sex
  • Aged 18-65 years
  • Candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy

排除标准

  • the patients with kidney failure, liver failure, valvular and ischemic heart disease , high blood pressure, diabetes, history of infection and malignancy.
  • history of coagulation diseases, and history of drug allergies to used drugs.
  • those who consumed NSAIDs and analgesics 24 h before surgery were excluded from the study.

研究组 & 干预措施

group of control (C)

Experimental

receive 18 ml of normal saline only and serve as the control group.the normal saline will injected in the knee joint by the surgeon through the arthroscope after completing the procedure

干预措施: Normal Saline (Placebo) (Drug)

groups of Bupivacaine (B)

Experimental

The 18ml 0.25% bupivacaine will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure

干预措施: Bupivacaine 0.25% (Drug)

groups of Bupivacaine (B)

Experimental

The 18ml 0.25% bupivacaine will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure

干预措施: Dexmedetomidine (Drug)

groups of dexmedetomidine (D)

Experimental

Dexmedetomidine 1 μg/kg will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Change on the visual analog scale (VAS) for pain (0 = no pain to 100 = the maximum pain )to assessment the duration of analgesia following the surgery

时间窗: post operative at 30 minute, 1 hour, 2 hour, 4 hour, 6 hour, 12 hour, and 24 hour .

Change on the visual analog scale (VAS) for pain (0 = no pain to 100 = the maximum pain) to assessment the duration of analgesia following intra articular injection of Bupivacaine and Dexmedetomidine after knee arthroscopy

次要结局

  • Total meperidine consumption . Meperidine will be used intravenously if the visual analog scale ( VAS) score was >50 to control postoperative pain.(The total dose of meperidine given between the study groups during the first 24 hour( post operative at 30 minute, 1 hour, 2 hour, 4 hour, 6 hour, 12 hour, and 24 hour),will be recorded.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Ali Mahmoud

Lecturer of anesthesia, intensive care and pain management

Al-Azhar University

研究点 (1)

Loading locations...

相似试验

Dexmedetomidine and Bupivacaine Intra-articular for... | 临床试验